within Pharmacolibrary.Drugs.V_Various.V09C_RenalSystem.V09CA06_Technetium99mtcEthylenedicysteine;

model Technetium99mtcEthylenedicysteine
  extends Pharmacolibrary.Drugs.ATC.V.V09CA06;

  annotation (Documentation(
info       = "<html><body><table><tr><td>Drug:</td><td>V09CA06</td></tr><td>route:</td><td>intravenous</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Technetium (99mTc) ethylenedicysteine is a radiopharmaceutical agent used in renal imaging for the assessment of kidney function, particularly dynamic renal scintigraphy. It is mainly used for imaging the kidneys to measure renal perfusion and function. This agent is approved in several countries and is used routinely in nuclear medicine.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters are estimated based on available literature for adults with normal renal function undergoing routine dynamic renal scintigraphy. No detailed compartmental PK study with quantifiable human PK parameters has been published.</p><h4>References</h4><ol><li><p>Kabasakal, L, et al., &amp; Onsel, C (1995). Evaluation of technetium-99m-ethylenedicysteine in renal disorders and determination of extraction ratio. <i>Journal of nuclear medicine : official publication, Society of Nuclear Medicine</i> 36(8) 1398–1403. PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/7629584/&quot;>https://pubmed.ncbi.nlm.nih.gov/7629584</a></p></li><li><p>Reddy, JA, et al., &amp; Leamon, CP (2004). Preclinical evaluation of (99m)Tc-EC20 for imaging folate receptor-positive tumors. <i>Journal of nuclear medicine : official publication, Society of Nuclear Medicine</i> 45(5) 857–866. PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/15136637/&quot;>https://pubmed.ncbi.nlm.nih.gov/15136637</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end Technetium99mtcEthylenedicysteine;
